Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors

NCT00006018 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: BMS-214662
DRUG: paclitaxel

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]